News Fit to Post: Two Views

In response to the editorial on what constitutes science news,1 I applaud the reporters for giving us "the good, the bad, and the ugly." The whole story is very important. I wouldn't want to make a decision on an item just knowing the half-truth. I'd be highly suspicious of anything that was reported as always sunny.Anything affecting science, as you say, is news. Be it good or bad, it needs to be told.It's disturbing to see one story reported several different ways from several different sites/

Written byTonya Topete
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In response to the editorial on what constitutes science news,1 I applaud the reporters for giving us "the good, the bad, and the ugly." The whole story is very important. I wouldn't want to make a decision on an item just knowing the half-truth. I'd be highly suspicious of anything that was reported as always sunny.

Anything affecting science, as you say, is news. Be it good or bad, it needs to be told.

It's disturbing to see one story reported several different ways from several different sites/reporters/journals because someone didn't want to include the good or the bad. Bias to one side or the other doesn't make it news ... it becomes opinion.

So keep reporting all sides of the story.

Tonya Topete tonya_topete@yahoo.com

I did not read your initial report of W. French Anderson's illegal actions, but I have to say that I disagree with the position on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies